RT Journal Article
SR Electronic
T1 Is MS affecting the CNS only?
JF Neurology - Neuroimmunology Neuroinflammation
JO Neurol Neuroimmunol Neuroinflamm
FD Lippincott Williams & Wilkins
SP e914
DO 10.1212/NXI.0000000000000914
VO 8
IS 1
A1 Ellen Oudejans
A1 Antonio Luchicchi
A1 Eva M.M. Strijbis
A1 Jeroen J.G. Geurts
A1 Anne-Marie van Dam
YR 2021
UL http://nn.neurology.org/content/8/1/e914.abstract
AB MS is regarded as a disease of the CNS where a combination of demyelination, inflammation, and axonal degeneration results in neurologic disability. However, various studies have also shown that the peripheral nervous system (PNS) can be involved in MS, expanding the consequences of this disorder outside the brain and spinal cord, and providing food for thought to the still unanswered questions about MS origin and treatment. Here, we review the emerging concept of PNS involvement in MS by looking at it from a clinical, molecular, and biochemical point of view. Clinical, pathologic, electrophysiologic, and imaging studies give evidence that the PNS is functionally affected during MS and suggest that the disease might be part of a spectrum of demyelinating disorders instead of being a distinct entity. At the molecular level, similarities between the anatomic structure of the myelin and its interaction with axons in CNS and PNS are evident. In addition, a number of biochemical alterations that affect the myelin during MS can be assumed to be shared between CNS and PNS. Involvement of the PNS as a relevant disease target in MS pathology may have consequences for reaching the diagnosis and for therapeutic approaches of patients with MS. Hence, future MS studies should pay attention to the involvement of the PNS, i.e., its myelin, in MS pathogenesis, which could advance MS research.AMS=axo-myelinic synapse; CCPD=combined central and peripheral demyelination; CNP=cyclic nucleotide phosphodiesterase; dMAG=degraded form of MAG; Ig-CAM=immunoglobulin-like cell adhesion molecule; MAG=myelin-associated glycoprotein; MBP=myelin basic protein; NFasc=neurofascin; NMDAR=NMDA receptor; NRG1 type III=neuregulin-1; OPC=oligodendrocyte progenitor cell; PAD=peptidyl arginine deiminase; PLP=proteolipid protein; PNS=peripheral nervous system; P0=myelin protein 0; RRMS=relapsing-remitting MS